Literature DB >> 33505777

Non-Invasive Strategies for Nose-to-Brain Drug Delivery.

J T Trevino1, R C Quispe1, F Khan1, V Novak1.   

Abstract

Intranasal drug administration is a promising method for delivering drugs directly to the brain. Animal studies have described pathways and potential brain targets, but nose-to-brain delivery and treatment efficacy in humans remains debated. We describe the proposed pathways and barriers for nose-to-brain drug delivery in humans, drug properties that influence central nervous system delivery, clinically tested methods to enhance absorption, and the devices used in clinical trials. This review compiles the available evidence for nose-to-brain drug delivery in humans and summarizes the factors involved in nose-to-brain drug delivery.

Entities:  

Keywords:  Bioavailability; Biodistribution; Devices; Intranasal administration; Nose-to-brain

Year:  2020        PMID: 33505777      PMCID: PMC7836101     

Source DB:  PubMed          Journal:  J Clin Trials        ISSN: 2167-0870


  171 in total

Review 1.  Transport of drugs from the nasal cavity to the central nervous system.

Authors:  L Illum
Journal:  Eur J Pharm Sci       Date:  2000-07       Impact factor: 4.384

2.  Immediate but not long-term intranasal administration of insulin raises blood pressure in human beings.

Authors:  Christian Benedict; Christoph Dodt; Manfred Hallschmid; Marc Lepiorz; Horst L Fehm; Jan Born; Werner Kern
Journal:  Metabolism       Date:  2005-10       Impact factor: 8.694

3.  Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

Authors:  Suzanne Craft; Laura D Baker; Thomas J Montine; Satoshi Minoshima; G Stennis Watson; Amy Claxton; Matthew Arbuckle; Maureen Callaghan; Elaine Tsai; Stephen R Plymate; Pattie S Green; James Leverenz; Donna Cross; Brooke Gerton
Journal:  Arch Neurol       Date:  2011-09-12

Review 4.  Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.

Authors:  Chandrakantsing Vijaysing Pardeshi; Veena Shailendra Belgamwar
Journal:  Expert Opin Drug Deliv       Date:  2013-04-16       Impact factor: 6.648

5.  Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.

Authors:  Clovis O da Fonseca; Marcela Simão; Igor R Lins; Regina O Caetano; Débora Futuro; Thereza Quirico-Santos
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-18       Impact factor: 4.553

6.  Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery.

Authors:  Niyanta N Kumar; Jeffrey J Lochhead; Michelle E Pizzo; Geetika Nehra; Sam Boroumand; Gretchen Greene; Robert G Thorne
Journal:  J Control Release       Date:  2018-08-04       Impact factor: 9.776

Review 7.  Glutathione--a review on its role and significance in Parkinson's disease.

Authors:  Heather L Martin; Peter Teismann
Journal:  FASEB J       Date:  2009-06-19       Impact factor: 5.191

8.  A review on mucoadhesive polymer used in nasal drug delivery system.

Authors:  Mayank Chaturvedi; Manish Kumar; Kamla Pathak
Journal:  J Adv Pharm Technol Res       Date:  2011-10

9.  Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans.

Authors:  Kamila Jauch-Chara; Alexia Friedrich; Magdalena Rezmer; Uwe H Melchert; Harald G Scholand-Engler; Manfred Hallschmid; Kerstin M Oltmanns
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

10.  Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism.

Authors:  Giselle M Faria; Igor D P Soares; Marcela D'Alincourt Salazar; Marcia R Amorim; Bruno L Pessoa; Clovis O da Fonseca; Thereza Quirico-Santos
Journal:  BMC Cancer       Date:  2020-04-07       Impact factor: 4.430

View more
  4 in total

1.  Using nanotechnology to deliver biomolecules from nose to brain - peptides, proteins, monoclonal antibodies and RNA.

Authors:  Mireya L Borrajo; María José Alonso
Journal:  Drug Deliv Transl Res       Date:  2021-11-03       Impact factor: 4.617

2.  MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial.

Authors:  Vera Novak; Christos S Mantzoros; Peter Novak; Regina McGlinchey; Weiying Dai; Vasileios Lioutas; Stephanie Buss; Catherine B Fortier; Faizan Khan; Laura Aponte Becerra; Long H Ngo
Journal:  J Neurol       Date:  2022-04-28       Impact factor: 6.682

Review 3.  Metal-Based Nanostructured Therapeutic Strategies for Glioblastoma Treatment-An Update.

Authors:  Agata M Gawel; Ravi Singh; Waldemar Debinski
Journal:  Biomedicines       Date:  2022-07-05

Review 4.  Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects.

Authors:  Amarjitsing Rajput; Prashant Pingale; Vividha Dhapte-Pawar
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.